← SynDRA
AZD-3839
SynDRA canonical compound SYN0034160 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | BACE1 |
|---|
| Mechanism of action | beta-secretase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- BACE1 COMPETITIVE
- beta-secretase inhibitor
Cross-references
Synonyms
- AZD3839
- GTPL6931
- 4b05
- (3S)-3-[2-(difluoromethyl)pyridin-4-yl]-7-fluoro-3-[3-(pyrimidin-5-yl)phenyl]-2,3-dihydro-1H-isoindol-1-amine
- 32D
- I8ID590133
- RefChem:115997
- AZD3839 free base
- AZD3839 (free base)
- C24H16F3N5
- orb1300481
- SCHEMBL1358337
- SCHEMBL29430228
- SCHEMBL29774125
- SCHEMBL30477099
- UNII-I8ID590133
- AZD 3839 [WHO-DD]
- HMS3753C11
- HMS3886L17
- AZD3839?
- CZB16384
- EX-A2576
- BDBM50398264
- s7731
- AKOS032945038
- CCG-269020
- CS-5933
- NCGC00481568-01
- AC-36154
- BS-15015
- HY-13438
- NS00072906
- T6772
- F85452
- F866411
- EX-A6697
- orb1738769
- AZD3839 hemifumarate
Look up AZD-3839 in the interactive SynDRA portal →